tm logo

Monitor this mark

View On USPTO

INFUTREL
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 10 Sep 2024

Last Applicant/ Owned by

Sandoz Canada Inc.

145, rue Jules-Léger

Boucherville, Quebec

CA

J4B7K8

Serial Number

97677779 filed on 15th Nov 2022

Registration Number

N/A

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC

RALEIGH, NC 27609

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

INFUTREL

Trace elements for injection, namely, dietetic infusions for medical use containing copper, chromium, zinc, selenium, manganese, iron, iodine, fluoride and molybdenum for parenteral infusion

Classification Information

Class [005]
Pharmaceutical Products

Trace elements for injection, namely, dietetic infusions for medical use containing copper, chromium, zinc, selenium, manganese, iron, iodine, fluoride and molybdenum for parenteral infusion

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97677779

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
10th Sep 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Jul 2024PUBLISHED FOR OPPOSITION
26th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
07th Jun 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
07th Jun 2024TEAS/EMAIL CORRESPONDENCE ENTERED
07th Jun 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
29th May 2024CONTINUATION OF FINAL REFUSAL E-MAILED
29th May 2024ACTION CONTINUING A FINAL - COMPLETED